Recombinant Streptococcus equi subsp. equi Prolipoprotein diacylglyceryl transferase (lgt)

What is the role of prolipoprotein diacylglyceryl transferase (lgt) in Streptococcus equi subsp. equi?

Prolipoprotein diacylglyceryl transferase (lgt) catalyzes the first and committed step in the lipoprotein processing pathway in Gram-positive bacteria, including S. equi. This enzyme is responsible for the lipid modification of proteins, specifically the transfer of a diacylglyceryl moiety from phosphatidylglycerol to the sulfhydryl group of the invariant cysteine residue in the lipobox of prolipoproteins. This post-translational modification is critical for the proper anchoring of lipoproteins to the bacterial cell membrane. In S. equi, lgt mutants show altered lipoprotein processing, affecting their localization within the cell envelope and potentially impacting various cellular functions, including virulence .

What are the most effective methods for creating lgt mutants in S. equi?

Creating effective lgt mutants in S. equi involves several methodological approaches, with allelic replacement being the most commonly employed strategy. Based on published research, the following protocol has proven successful:

• Target Selection: Identify the lgt gene sequence from the S. equi genome database.

• Construct Design: Design PCR primers to amplify regions flanking the target lgt gene or portion to be deleted.

• Vector Construction: Clone these flanking regions into a temperature-sensitive shuttle vector (e.g., pG+host9) with a selectable antibiotic resistance marker.

• Transformation: Transform the construct into S. equi using electroporation (typically at 2.5 kV, 200 Ω, and 25 μF).

• Selection Process: Select transformants on media containing appropriate antibiotics at permissive temperature (28°C).

• Integration: Shift to non-permissive temperature (37°C) while maintaining antibiotic selection to force plasmid integration.

• Excision: Release antibiotic selection and maintain at permissive temperature to allow second recombination event.

• Screening: Screen colonies for successful deletion using PCR verification of the targeted region.

For specifically creating Δlgt190-685 mutants as described in the literature, researchers targeted nucleotides 190-685 of the lgt gene for deletion, resulting in a truncated and non-functional protein while maintaining the reading frame .

How can researchers effectively assess the impact of lgt mutations on lipoprotein processing?

Assessing the impact of lgt mutations on lipoprotein processing requires a multi-faceted approach combining biochemical, immunological, and functional methods:

• Western Blot Analysis: Using antibodies specific to known lipoproteins (e.g., LppC acid phosphatase) to detect altered migration patterns. In wild-type strains, mature lipoproteins show specific banding patterns, while in lgt mutants, different patterns emerge due to improper processing.

• Globomycin Treatment Comparison: Treating wild-type strains with globomycin (an inhibitor of lipoprotein signal peptidase II) creates a control that can be compared with lgt mutants to visualize processing defects.

• Enzymatic Activity Assays: For lipoproteins with known enzymatic functions (like LppC acid phosphatase), activity assays can quantify functional impacts. As shown in research, acid phosphatase activity at pH 5 is significantly reduced in Δlgt190-685 mutants compared to wild-type S. equi .

• Immunogold Labeling and Electron Microscopy: This technique quantifies the localization of lipoproteins in the cell envelope. Studies have shown that individual S. equi 4047 cocci (n=10) displayed 234±20 gold particles compared to only 54±20 particles in Δlgt190-685 mutants .

• Membrane Fractionation: Separating membrane and cytosolic fractions followed by proteomic analysis can identify mislocalized lipoproteins in mutant strains.

Table 1: Comparison of LppC Detection Methods in Wild-type and Δlgt190-685 S. equi Strains

What in vitro models are suitable for studying S. equi colonization and the role of lgt?

Several in vitro models have proven effective for studying S. equi colonization and the role of lgt, with air-interface organ cultures being particularly valuable:

• Air-Interface Organ Cultures: These cultures use tissues derived from equine upper respiratory tract (URT) maintained at an air interface rather than submerged, providing a more physiological infection environment. Tissues from nasal turbinate, guttural pouch, and trachea can be maintained viable and contamination-free for experimental durations. Research has shown that wild-type S. equi cells preferentially colonize nasal turbinate and guttural pouch tissues over tracheal tissues, with quantifiable differences in colonization between wild-type and lgt mutant strains .

• Adherence Assays: Using equine epithelial cell lines to quantify bacterial attachment. After co-incubation of bacteria with cells, non-adherent bacteria are removed by washing, and adherent bacteria are quantified by dilution plating.

• Biofilm Formation Assays: Crystal violet staining or confocal microscopy can assess the ability of wild-type versus lgt mutant strains to form biofilms on relevant surfaces.

• Ex Vivo Tissue Explants: Freshly harvested equine tissues can be used for short-term colonization studies, providing a complex tissue architecture that better mimics in vivo conditions.

• Mucus Production Quantification: Measuring mucus production in response to bacterial infection provides insights into host tissue responses. Studies have shown that both wild-type S. equi and Δlgt190-685 infections induce significant mucus production in organ cultures, though with quantifiable differences .

The selection of an appropriate model depends on the specific aspect of S. equi-host interaction under investigation, with air-interface organ cultures providing the most comprehensive assessment of colonization dynamics.

How should researchers interpret contradictory virulence data between in vitro and in vivo models for lgt mutants?

Interpreting contradictory virulence data between in vitro and in vivo models requires a systematic approach considering multiple factors:

• Model Complexity Analysis: In vitro models are simplified systems that may not capture the full complexity of host-pathogen interactions. While S. equi lgt mutants may show specific phenotypes in vitro (like altered colonization of air-interface organ cultures), the in vivo environment introduces additional factors such as systemic immune responses, fluid dynamics, and competing microbiota that can influence outcomes. Researchers should explicitly acknowledge these limitations when interpreting conflicting data.

• Temporal Considerations: In vitro experiments typically assess short-term interactions (hours to days), while in vivo models may measure outcomes over longer periods. The Δlgt190-685 mutation might have different effects at different stages of infection. Analysis should consider whether contradictions reflect true biological differences or merely temporal discrepancies in measurement.

• Quantitative vs. Qualitative Assessment: Research has shown that lgt mutants may be attenuated in mouse models despite retaining some virulence capacity. In one study, 2 of 30 mice infected with the Δlgt mutant still developed disease, suggesting attenuated but not eliminated virulence . Such quantitative differences may explain apparent contradictions if binary (yes/no) outcomes are being compared across models.

• Host-Specific Effects: For S. equi, data from the mouse model must be cautiously extrapolated to the natural equine host. The observed virulence attenuation in mice might manifest differently in horses due to species-specific immune responses or receptor distributions.

When faced with contradictory data, researchers should conduct parallel experiments using standardized inocula and matched time points across models to determine whether discrepancies are methodological or biological in nature.

What statistical approaches are most appropriate for analyzing bacterial burden data in lgt mutation studies?

When analyzing bacterial burden data in lgt mutation studies, several statistical approaches are appropriate depending on the experimental design and data characteristics:

• For Normally Distributed Data:

  • Unpaired t-tests are suitable for comparing bacterial burdens between two groups (e.g., wild-type vs. lgt mutant).

  • One-way ANOVA followed by Tukey's or Dunnett's post-hoc tests for multiple group comparisons (e.g., wild-type vs. multiple different mutants).

• For Non-Normally Distributed Data:

  • Mann-Whitney U test for two-group comparisons.

  • Kruskal-Wallis test followed by Dunn's post-hoc test for multiple comparisons.

• For Time-Course Experiments:

  • Repeated measures ANOVA or mixed-effects models are appropriate for analyzing changes in bacterial burden over time.

  • Area under the curve (AUC) analysis can summarize bacterial burden across multiple timepoints into a single value for comparison.

• For Survival Analysis:

  • Kaplan-Meier survival curves with log-rank tests are appropriate when measuring time-to-event outcomes (e.g., time to onset of clinical signs or mortality).

• Sample Size Considerations:

  • Power analysis should be conducted prior to experiments to ensure sufficient statistical power.

  • For studies similar to those examining S. equi lgt mutants in mice, a minimum of 10-15 animals per group is typically necessary to detect meaningful differences in bacterial burden.

When reporting results, it's essential to present both the magnitude of differences (e.g., mean or median differences with confidence intervals) and statistical significance (p-values). Data transformation (e.g., log transformation of CFU counts) is often necessary to meet the assumptions of parametric tests.

How can researchers differentiate between direct effects of lgt mutation and indirect effects due to altered expression of other virulence factors?

Differentiating between direct effects of lgt mutation and indirect effects requires a comprehensive approach combining multiple methodologies:

• Complementation Studies: Reintroducing a functional lgt gene into the mutant strain should restore the wild-type phenotype if effects are directly attributable to lgt. This approach remains the gold standard for confirming genotype-phenotype relationships.

• Transcriptomic Analysis: RNA sequencing or microarray analysis comparing wild-type and lgt mutant strains can identify altered gene expression patterns that might contribute to phenotypic changes. This approach can reveal whether the lgt mutation triggers compensatory responses or regulatory cascades affecting other virulence factors.

• Proteomic Profiling: Comparative proteomics of wild-type and mutant strains can identify proteins with altered abundance or localization. For S. equi lgt mutants, this approach has revealed altered processing and localization of specific lipoproteins like LppC .

• Targeted Gene Expression Analysis: qRT-PCR for known virulence genes can determine if their expression is altered in the lgt mutant background.

• Functional Assays for Specific Virulence Mechanisms: Assays targeting specific virulence mechanisms (e.g., adhesion, invasion, toxin production) can help determine which aspects of virulence are altered in lgt mutants.

• Double Mutant Analysis: Creating double mutants (lgt plus another virulence factor) can help establish hierarchical relationships and interactions between virulence determinants.

By implementing this multi-faceted approach, researchers can build a comprehensive understanding of the direct mechanistic consequences of lgt mutation versus secondary effects mediated through altered expression or function of other virulence factors.

What are the molecular mechanisms by which lipoproteins processed by lgt contribute to immune evasion in S. equi infections?

The molecular mechanisms by which lgt-processed lipoproteins contribute to immune evasion in S. equi involve several sophisticated pathways:

While these mechanisms are supported by experimental evidence in various bacterial systems, further research is needed to characterize the specific contributions of individual lgt-processed lipoproteins to immune evasion in S. equi infections.

How does the substrate specificity of S. equi lgt compare with that of other bacterial species, and what are the implications for cross-species vaccine development?

The substrate specificity of S. equi lgt shares commonalities with other bacterial species but also exhibits distinctive characteristics that impact cross-species vaccine development:

The substrate flexibility of lgt suggests that recombinant expression systems could be engineered to produce properly modified S. equi lipoproteins for vaccine development, potentially offering cross-protection against multiple streptococcal species if conserved lipoproteins are targeted.

What role do lgt-processed lipoproteins play in biofilm formation and persistence in equine respiratory tissues?

Lgt-processed lipoproteins contribute significantly to biofilm formation and persistence in equine respiratory tissues through several mechanisms:

• Initial Attachment: Properly processed lipoproteins function as adhesins that mediate the initial attachment of S. equi to host tissues. Air-interface organ culture studies have shown that wild-type S. equi cells adhere more efficiently to nasal turbinate and guttural pouch tissues compared to lgt mutants, suggesting that lipoproteins contribute to tissue tropism . This initial attachment is a prerequisite for subsequent biofilm formation.

• Intercellular Aggregation: Following attachment, some lipoproteins facilitate bacteria-bacteria interactions, promoting the aggregation necessary for biofilm development. The reduced cell-envelope localization of lipoproteins in lgt mutants (demonstrated by immunogold labeling showing only 54±20 gold particles per cell compared to 234±20 in wild-type) likely impairs these intercellular interactions.

• Extracellular Matrix Production: Certain lipoproteins may be involved in the production or modification of extracellular polymeric substances (EPS) that form the biofilm matrix. The altered membrane protein composition in lgt mutants potentially affects EPS production, though this requires further investigation specifically in S. equi.

• Environmental Sensing and Adaptation: Lipoproteins often function as components of two-component systems or other signaling pathways that sense environmental conditions and regulate biofilm-associated genes. Improperly processed lipoproteins in lgt mutants may compromise these sensing mechanisms, affecting the bacteria's ability to adapt to the equine respiratory environment.

• Immune Evasion Within Biofilms: Mature biofilms provide protection against host defenses, and lipoproteins may enhance this protection through specific immune evasion mechanisms, as discussed in FAQ 4.1. The mucus production observed in response to both wild-type and lgt mutant infections suggests complex host-pathogen interactions during biofilm establishment .

Future research directions should include comparative biofilm assays between wild-type and lgt mutant strains on relevant substrates, coupled with transcriptomic analysis of biofilm-associated genes to further elucidate the specific contributions of lgt-processed lipoproteins to persistence in the equine host.

What are the most promising approaches for developing attenuated live vaccines based on lgt mutations in S. equi?

Developing attenuated live vaccines based on lgt mutations in S. equi presents several promising approaches:

• Rational Attenuation Strategy: Rather than complete lgt deletion, creating targeted mutations that partially reduce function may achieve the optimal balance between attenuation and immunogenicity. The Δlgt190-685 mutant, which shows significant attenuation while maintaining some lipoprotein processing, provides a starting point for this approach .

• Complementary Mutations: Combining lgt mutations with alterations in other virulence factors could create synergistically attenuated strains with enhanced safety profiles. Potential targets include:

  • PrtM mutations, as the Δprtm138-213 mutant shows attenuation similar to lgt mutants

  • Toxin gene deletions

  • Capsule synthesis gene modifications

• Controlled Expression Systems: Developing strains with inducible or temporally regulated lgt expression could allow for initial colonization followed by controlled attenuation, potentially enhancing immune responses while maintaining safety.

• Tissue-Specific Attenuation: Engineering lgt mutants with tissue-specific promoters could restrict replication to non-pathogenic niches while still inducing protective immunity.

• Heterologous Antigen Expression: Using attenuated lgt mutants as platforms for expressing additional protective antigens could enhance vaccine efficacy. The SeM protein has shown promise as a vaccine antigen when expressed in E. coli , and could be overexpressed in attenuated S. equi strains.

Table 2: Comparative Analysis of Potential Live Attenuated Vaccine Approaches

Each approach presents unique advantages and challenges, with the optimal strategy likely involving a combination of these approaches tailored to the specific requirements of equine vaccination.

How might high-throughput screening methods be applied to identify specific lipoproteins dependent on lgt that contribute most significantly to virulence?

High-throughput screening methods offer powerful approaches to identify lgt-dependent lipoproteins that significantly contribute to virulence:

• Transposon Mutagenesis Followed by Deep Sequencing (Tn-Seq):

  • Generate a comprehensive transposon mutant library in wild-type S. equi

  • Generate a parallel library in Δlgt background

  • Infect appropriate models (mouse or equine) with both libraries

  • Compare the fitness profiles of individual lipoprotein mutants in both backgrounds

  • Lipoproteins showing significantly different fitness impacts between wild-type and Δlgt backgrounds are likely lgt-dependent virulence factors

• CRISPR Interference (CRISPRi) Screening:

  • Design a sgRNA library targeting predicted lipoprotein genes

  • Deploy the library in wild-type and Δlgt backgrounds

  • Assess differential fitness impacts in infection models

  • This approach allows for controlled, partial gene repression rather than complete knockout

• Proteomics-Based Methods:

  • Comparative Surface Proteomics: Compare surface-accessible proteins between wild-type and Δlgt mutants using biotinylation and mass spectrometry

  • Pulse-Chase Proteomics: Track the fate of newly synthesized lipoproteins in both backgrounds

  • Differential Detergent Extraction: Systematically extract proteins with increasing detergent strengths to identify differentially localized lipoproteins

• Functional Genomics Approaches:

  • Arrayed Overexpression Library: Systematically overexpress individual lipoproteins in the Δlgt background to identify those that restore virulence

  • Pooled Complementation: Introduce libraries of lipoprotein expression constructs into Δlgt mutants and select for restored virulence in vivo

• Machine Learning Integration:

  • Develop predictive models incorporating sequence features, structural predictions, and experimental data to prioritize lipoproteins for functional validation

  • This approach can significantly reduce the experimental burden by focusing on high-probability candidates

By combining these high-throughput approaches, researchers can rapidly identify the subset of lgt-dependent lipoproteins that most significantly contribute to virulence, providing targeted candidates for further mechanistic studies and vaccine development.

What are the major technical challenges in expressing and purifying functional recombinant S. equi lgt for structural studies?

Expressing and purifying functional recombinant S. equi lgt for structural studies presents several major technical challenges:

• Membrane Protein Expression Issues:

  • Toxicity to Expression Hosts: Overexpression of membrane proteins like lgt often causes toxicity in common expression hosts such as E. coli.

  • Inclusion Body Formation: High-level expression frequently leads to protein misfolding and aggregation into inclusion bodies.

  • Solution: Using tunable expression systems (e.g., PBAD, T7lac) with lower induction levels, specialized E. coli strains (C41/C43), or alternative hosts like Lactococcus lactis may improve soluble expression.

• Maintaining Native Conformation:

  • Detergent Selection: Identifying detergents that efficiently solubilize lgt while preserving its native conformation and activity is challenging.

  • Lipid Requirements: Lgt likely requires specific lipid environments for proper folding and function.

  • Solution: Systematic screening of detergent panels, including mild non-ionic detergents (DDM, LMNG), combined with lipid supplementation during purification.

• Purification Challenges:

  • Multiple Purification Steps: Achieving high purity typically requires multiple chromatography steps, each potentially reducing yield and activity.

  • Protein Stability: Lgt may exhibit limited stability once removed from the membrane environment.

  • Solution: Employing affinity tags (His, Strep) for efficient capture, followed by size exclusion chromatography in optimized buffer conditions with appropriate detergents and stabilizing additives.

• Functional Validation:

  • Activity Assay Development: Establishing reliable in vitro assays to confirm that purified lgt retains enzymatic activity.

  • Substrate Availability: Producing suitable prolipoprotein substrates for activity testing.

  • Solution: Adapting published paper electrophoretic assays or developing fluorescence-based assays using synthetic peptide substrates.

• Crystallization Barriers:

  • Conformational Heterogeneity: Membrane proteins often exhibit flexibility that hampers crystallization.

  • Detergent Micelle Interference: Detergent micelles can prevent crystal contacts.

  • Solution: Employing lipidic cubic phase (LCP) crystallization, antibody fragment co-crystallization, or cryo-electron microscopy as alternatives to traditional crystallization approaches.

Recent advances suggest that the peripheral membrane association of lgt, rather than integral transmembrane topology, might be advantageous for structural studies. The observation that soluble lgt maintains enzymatic activity similar to membrane-bound forms indicates that successful structural studies may be possible with appropriate expression and purification strategies focused on capturing the active, peripheral membrane-associated form of the enzyme.

What are the ethical considerations and guidelines for conducting S. equi infection studies in the natural equine host?

Conducting S. equi infection studies in the natural equine host requires careful attention to several ethical considerations and adherence to specific guidelines:

• Regulatory Compliance and Approval:

  • All studies must receive prior approval from the Institutional Animal Care and Use Committee (IACUC) or equivalent ethics committee.

  • Research must comply with national regulations such as the Animal Welfare Act and institutional policies governing large animal research.

  • For many jurisdictions, S. equi research requires specific biosafety approvals due to its contagious nature.

• Experimental Design Considerations:

  • Replacement: Whenever possible, in vitro methods such as air-interface organ cultures should be used before proceeding to in vivo studies .

  • Reduction: Statistical power analyses must be conducted to determine the minimum number of animals required to obtain scientifically valid results.

  • Refinement: Procedures should be designed to minimize pain, suffering, and distress, including appropriate anesthesia and analgesia protocols.

• Animal Selection and Housing:

  • Use purpose-bred research horses rather than rescued animals when possible to ensure known health status.

  • Horses should be screened for pre-existing S. equi antibodies and carriers excluded to prevent confounding results.

  • Housing must include appropriate quarantine facilities with negative pressure ventilation systems to prevent pathogen spread.

• Clinical Monitoring and Endpoints:

  • Implement comprehensive clinical scoring systems to objectively assess disease progression.

  • Establish clear humane endpoints defining conditions under which animals will be removed from the study and provided with appropriate veterinary care or euthanasia.

  • Continuous monitoring by qualified veterinary staff is essential, with 24-hour availability for emergency care.

• Sample Collection and Minimally Invasive Techniques:

  • Develop sampling protocols that minimize discomfort while maximizing scientific value.

  • Consider endoscopic techniques for upper respiratory tract sampling rather than more invasive approaches.

  • Limit the frequency and volume of blood collection according to established guidelines.

• Biosecurity and Public Health Considerations:

  • Implement strict infection control measures to prevent inadvertent transmission to other horses or facilities.

  • Personnel must use appropriate personal protective equipment and follow decontamination protocols.

  • Proper disposal of contaminated materials according to institutional biosafety guidelines is mandatory.

By adhering to these ethical considerations and guidelines, researchers can conduct scientifically valid S. equi infection studies while ensuring the welfare of the equine subjects and protecting public health.

How can computational modeling be used to predict the effects of lgt mutations on S. equi pathogenesis?

Computational modeling offers powerful approaches to predict the effects of lgt mutations on S. equi pathogenesis:

• Structural Bioinformatics Approaches:

  • Homology Modeling: Using known bacterial lgt structures as templates to predict the S. equi lgt structure and simulate the effects of specific mutations on enzyme function.

  • Molecular Dynamics Simulations: Exploring how mutations affect protein dynamics, substrate binding, and catalytic mechanisms in atomic detail.

  • Protein-Lipid Interaction Modeling: Predicting how mutations might alter membrane association, which is particularly relevant given the peripheral membrane association of lgt .

• Systems Biology Modeling:

  • Genome-Scale Metabolic Models: Integrating lipoprotein processing into whole-cell metabolic models to predict systemic effects of lgt mutations.

  • Regulatory Network Analysis: Modeling how altered lipoprotein processing might affect regulatory networks controlling virulence gene expression.

  • Host-Pathogen Interaction Networks: Predicting changes in host-pathogen protein interaction networks when lipoprotein processing is compromised.

• Machine Learning Prediction Frameworks:

  • Virulence Prediction Algorithms: Training algorithms on existing data to predict virulence impacts of novel lgt mutations.

  • Epitope Prediction: Identifying how altered lipoprotein processing affects immunogenicity and potential immune evasion.

  • Sequence-Based Function Prediction: Using deep learning approaches to predict functional consequences of mutations based on sequence context.

• Multi-Scale Modeling Approaches:

  • Molecular-to-Cellular Integration: Linking molecular-level changes in lipoprotein processing to cellular-level phenotypes.

  • Population Dynamics Models: Predicting how lgt mutations might affect bacterial population dynamics during infection.

  • Host Response Modeling: Simulating immune response trajectories to wild-type versus mutant strains.

• Implementation Strategy:

  • Begin with atomic-level modeling of lgt and its interactions with substrate proteins.

  • Integrate predictions into cellular-level models incorporating lipoprotein localization.

  • Scale up to tissue-level infection models that account for bacterial-host interactions.

  • Validate computational predictions with targeted experiments in simplified systems before testing in complex models.

The effectiveness of computational approaches will depend on integration with experimental validation, with iterative refinement of models based on experimental outcomes. As computational power increases and machine learning models improve, the predictive accuracy of these approaches for understanding lgt mutations' effects on S. equi pathogenesis will continue to advance.

What is the current consensus on the evolutionary significance of lipoprotein processing pathways across different bacterial pathogens?

The current consensus on the evolutionary significance of lipoprotein processing pathways across bacterial pathogens encompasses several key perspectives:

• Conservation and Divergence Patterns:

  • The lgt-dependent lipoprotein processing pathway is highly conserved across bacterial phylogeny, suggesting fundamental importance.

  • While the core machinery (lgt, lsp, lnt in Gram-negative bacteria) is conserved, the substrate repertoire (lipoproteins) shows remarkable divergence even between closely related species.

  • This pattern suggests that the processing mechanism is under strong purifying selection while the lipoprotein repertoire rapidly evolves in response to niche-specific pressures.

• Variable Contribution to Virulence:

  • The impact of lgt mutations on virulence varies significantly across bacterial species. While lgt mutation attenuates virulence in S. equi , Streptococcus suis lsp mutations do not appear to attenuate virulence in piglet models .

  • This variability suggests that different pathogens have evolved different dependencies on properly processed lipoproteins for virulence.

• Host-Pathogen Co-Evolution:

  • The lipid moiety added by lgt is recognized by host TLR2, creating selective pressure for pathogens to modulate this interaction.

  • Evidence suggests convergent evolution of mechanisms to either evade or exploit TLR2 recognition across diverse bacterial lineages.

  • In S. equi, lipoproteins may have evolved to fine-tune immune responses in the equine host, explaining the host-specific nature of the pathogen.

• Horizontal Gene Transfer and Niche Adaptation:

  • While the processing machinery is vertically inherited, many lipoproteins show evidence of horizontal gene transfer.

  • This pattern enables rapid adaptation to new niches through acquisition of novel lipoproteins while maintaining the core processing pathway.

  • The S. equi genome shows evidence of mobile genetic elements and prophages containing virulence-associated lipoproteins, suggesting horizontal acquisition during adaptation to the equine host.

• Functional Redundancy and Specialization:

  • Different lipoproteins often show functional redundancy, providing robustness to the bacterial cell.

  • This redundancy explains why mutation of individual lipoproteins sometimes shows minimal phenotypes, while disruption of the entire pathway through lgt mutation has more profound effects.

  • The observation that different lipoproteins are processed differently in lgt or lsp mutants suggests evolutionary specialization in processing pathways.